AI Meets Nature: Enveda’s Future of Drug Discovery

In this episode of Tech Innovators Spotlight, host Vrushali Soni and co-host Ahmed Halawani welcome August Allen to explore the cutting-edge world of AI-powered drug discovery with Enveda Biosciences. August Allen, CTO of Enveda, breaks down how the company is leveraging AI and mass spectrometry to unlock nature’s vast, untapped reservoir of medicinal molecules. With 99% of nature’s chemistry still undiscovered, Enveda’s innovative approach aims to accelerate drug discovery and bring new treatments to market faster than traditional methods. August also discusses PRISM, their collaboration with Microsoft, and how machine learning is revolutionizing the way scientists decode the "grammar of chemistry" for groundbreaking medical advancements. 

 

In This Episode You Will Learn:  

 

• How AI and machine learning are revolutionizing drug discovery 
• Why nature-derived compounds may lead to safer and more effective medicines 
• How Microsoft's partnership with Enveda is driving innovation in pharmaceutical research 

 

Some Questions We Ask: 

 

• Does using natural ingredients make drug development faster? 
• Can you explain mass spectrometry in simple terms? 
• AI is a big part of Enveda. How has it shaped the company since 2019? 

 

   

Resources:      

View Ahmed Halawani on LinkedIn  

View August Allen on LinkedIn  

View Vrushali Soni on LinkedIn  

  

Related Microsoft Podcasts:   

  

• Microsoft Threat Intelligence Podcast   
• Afternoon Cyber Tea with Ann Johnson   
• Microsoft Hybrid Cloud Partners Podcast   

  

  

Discover and follow other Microsoft podcasts at microsoft.com/podcasts   

Download the Transcript

---

Hosted on Acast. See acast.com/privacy for more information.